 | • レポートコード：MRC2312MG07994 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、74ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥721,500 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のナトリウムチャネル遮断剤市場規模と予測を収録しています。・世界のナトリウムチャネル遮断剤市場：売上、2018年-2023年、2024年-2029年 ・世界のナトリウムチャネル遮断剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のナトリウムチャネル遮断剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「クラスIA（キニジン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ナトリウムチャネル遮断剤のグローバル主要企業は、SK biopharmaceuticals、 Biogen、 Parion Sciences、 AlphaNavi Pharma、 WEX、 Vertex Pharmaceuticals、 RaQualia Pharma、 KBP Biosciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ナトリウムチャネル遮断剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のナトリウムチャネル遮断剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のナトリウムチャネル遮断剤市場：タイプ別市場シェア、2022年 ・クラスIA（キニジン、プロカインアミドなど）、クラスIB（リドカイン、フェニトイン、メキシレチンなど）、クラスIC（プロパフェノン、フレカイニドなど） 世界のナトリウムチャネル遮断剤市場：用途別、2018年-2023年、2024年-2029年 世界のナトリウムチャネル遮断剤市場：用途別市場シェア、2022年 ・注射剤、経口剤、その他 世界のナトリウムチャネル遮断剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のナトリウムチャネル遮断剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるナトリウムチャネル遮断剤のグローバル売上、2018年-2023年 ・主要企業におけるナトリウムチャネル遮断剤のグローバル売上シェア、2022年 ・主要企業におけるナトリウムチャネル遮断剤のグローバル販売量、2018年-2023年 ・主要企業におけるナトリウムチャネル遮断剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 SK biopharmaceuticals、 Biogen、 Parion Sciences、 AlphaNavi Pharma、 WEX、 Vertex Pharmaceuticals、 RaQualia Pharma、 KBP Biosciences ************************************************************* ・調査・分析レポートの概要 ナトリウムチャネル遮断剤市場の定義 市場セグメント 世界のナトリウムチャネル遮断剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のナトリウムチャネル遮断剤市場規模 世界のナトリウムチャネル遮断剤市場規模：2022年 VS 2029年 世界のナトリウムチャネル遮断剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのナトリウムチャネル遮断剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のナトリウムチャネル遮断剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：クラスIA（キニジン、プロカインアミドなど）、クラスIB（リドカイン、フェニトイン、メキシレチンなど）、クラスIC（プロパフェノン、フレカイニドなど） ナトリウムチャネル遮断剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：注射剤、経口剤、その他 ナトリウムチャネル遮断剤の用途別グローバル売上・予測 ・地域別市場分析 地域別ナトリウムチャネル遮断剤市場規模 2022年と2029年 地域別ナトリウムチャネル遮断剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） SK biopharmaceuticals、 Biogen、 Parion Sciences、 AlphaNavi Pharma、 WEX、 Vertex Pharmaceuticals、 RaQualia Pharma、 KBP Biosciences ... |
This research report provides a comprehensive analysis of the Sodium Channel Blockers market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Sodium Channel Blockers market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Sodium Channel Blockers, challenges faced by the industry, and potential opportunities for market players.
The global Sodium Channel Blockers market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Sodium Channel Blockers market presents opportunities for various stakeholders, including Injection, Oral. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Sodium Channel Blockers market. Additionally, the growing consumer demand present avenues for market expansion.
The global Sodium Channel Blockers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Sodium Channel Blockers market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Sodium Channel Blockers market.
Market Overview: The report provides a comprehensive overview of the Sodium Channel Blockers market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Class IA (Quinidine, Procainamide, etc.), Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Sodium Channel Blockers market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Sodium Channel Blockers market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Sodium Channel Blockers market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Sodium Channel Blockers market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Sodium Channel Blockers market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Sodium Channel Blockers market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Sodium Channel Blockers, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Sodium Channel Blockers market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Sodium Channel Blockers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Class IA (Quinidine, Procainamide, etc.)
Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
Class IC (Propafenone, Flecainide, etc.)
Market segment by Application
Injection
Oral
Others
Global Sodium Channel Blockers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
SK biopharmaceuticals
Biogen
Parion Sciences
AlphaNavi Pharma
WEX
Vertex Pharmaceuticals
RaQualia Pharma
KBP Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sodium Channel Blockers, market overview.
Chapter 2: Global Sodium Channel Blockers market size in revenue and volume.
Chapter 3: Detailed analysis of Sodium Channel Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sodium Channel Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sodium Channel Blockers capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Sodium Channel Blockers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sodium Channel Blockers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sodium Channel Blockers Overall Market Size
2.1 Global Sodium Channel Blockers Market Size: 2022 VS 2029
2.2 Global Sodium Channel Blockers Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Sodium Channel Blockers Sales: 2018-2029
3 Company Landscape
3.1 Top Sodium Channel Blockers Players in Global Market
3.2 Top Global Sodium Channel Blockers Companies Ranked by Revenue
3.3 Global Sodium Channel Blockers Revenue by Companies
3.4 Global Sodium Channel Blockers Sales by Companies
3.5 Global Sodium Channel Blockers Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sodium Channel Blockers Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sodium Channel Blockers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sodium Channel Blockers Players in Global Market
3.8.1 List of Global Tier 1 Sodium Channel Blockers Companies
3.8.2 List of Global Tier 2 and Tier 3 Sodium Channel Blockers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Sodium Channel Blockers Market Size Markets, 2022 & 2029
4.1.2 Class IA (Quinidine, Procainamide, etc.)
4.1.3 Class IB (Lidocaine, Phenytoin, Mexiletine, etc.)
4.1.4 Class IC (Propafenone, Flecainide, etc.)
4.2 By Type – Global Sodium Channel Blockers Revenue & Forecasts
4.2.1 By Type – Global Sodium Channel Blockers Revenue, 2018-2023
4.2.2 By Type – Global Sodium Channel Blockers Revenue, 2024-2029
4.2.3 By Type – Global Sodium Channel Blockers Revenue Market Share, 2018-2029
4.3 By Type – Global Sodium Channel Blockers Sales & Forecasts
4.3.1 By Type – Global Sodium Channel Blockers Sales, 2018-2023
4.3.2 By Type – Global Sodium Channel Blockers Sales, 2024-2029
4.3.3 By Type – Global Sodium Channel Blockers Sales Market Share, 2018-2029
4.4 By Type – Global Sodium Channel Blockers Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Sodium Channel Blockers Market Size, 2022 & 2029
5.1.2 Injection
5.1.3 Oral
5.1.4 Others
5.2 By Application – Global Sodium Channel Blockers Revenue & Forecasts
5.2.1 By Application – Global Sodium Channel Blockers Revenue, 2018-2023
5.2.2 By Application – Global Sodium Channel Blockers Revenue, 2024-2029
5.2.3 By Application – Global Sodium Channel Blockers Revenue Market Share, 2018-2029
5.3 By Application – Global Sodium Channel Blockers Sales & Forecasts
5.3.1 By Application – Global Sodium Channel Blockers Sales, 2018-2023
5.3.2 By Application – Global Sodium Channel Blockers Sales, 2024-2029
5.3.3 By Application – Global Sodium Channel Blockers Sales Market Share, 2018-2029
5.4 By Application – Global Sodium Channel Blockers Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Sodium Channel Blockers Market Size, 2022 & 2029
6.2 By Region – Global Sodium Channel Blockers Revenue & Forecasts
6.2.1 By Region – Global Sodium Channel Blockers Revenue, 2018-2023
6.2.2 By Region – Global Sodium Channel Blockers Revenue, 2024-2029
6.2.3 By Region – Global Sodium Channel Blockers Revenue Market Share, 2018-2029
6.3 By Region – Global Sodium Channel Blockers Sales & Forecasts
6.3.1 By Region – Global Sodium Channel Blockers Sales, 2018-2023
6.3.2 By Region – Global Sodium Channel Blockers Sales, 2024-2029
6.3.3 By Region – Global Sodium Channel Blockers Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Sodium Channel Blockers Revenue, 2018-2029
6.4.2 By Country – North America Sodium Channel Blockers Sales, 2018-2029
6.4.3 US Sodium Channel Blockers Market Size, 2018-2029
6.4.4 Canada Sodium Channel Blockers Market Size, 2018-2029
6.4.5 Mexico Sodium Channel Blockers Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Sodium Channel Blockers Revenue, 2018-2029
6.5.2 By Country – Europe Sodium Channel Blockers Sales, 2018-2029
6.5.3 Germany Sodium Channel Blockers Market Size, 2018-2029
6.5.4 France Sodium Channel Blockers Market Size, 2018-2029
6.5.5 U.K. Sodium Channel Blockers Market Size, 2018-2029
6.5.6 Italy Sodium Channel Blockers Market Size, 2018-2029
6.5.7 Russia Sodium Channel Blockers Market Size, 2018-2029
6.5.8 Nordic Countries Sodium Channel Blockers Market Size, 2018-2029
6.5.9 Benelux Sodium Channel Blockers Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Sodium Channel Blockers Revenue, 2018-2029
6.6.2 By Region – Asia Sodium Channel Blockers Sales, 2018-2029
6.6.3 China Sodium Channel Blockers Market Size, 2018-2029
6.6.4 Japan Sodium Channel Blockers Market Size, 2018-2029
6.6.5 South Korea Sodium Channel Blockers Market Size, 2018-2029
6.6.6 Southeast Asia Sodium Channel Blockers Market Size, 2018-2029
6.6.7 India Sodium Channel Blockers Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Sodium Channel Blockers Revenue, 2018-2029
6.7.2 By Country – South America Sodium Channel Blockers Sales, 2018-2029
6.7.3 Brazil Sodium Channel Blockers Market Size, 2018-2029
6.7.4 Argentina Sodium Channel Blockers Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Sodium Channel Blockers Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Sodium Channel Blockers Sales, 2018-2029
6.8.3 Turkey Sodium Channel Blockers Market Size, 2018-2029
6.8.4 Israel Sodium Channel Blockers Market Size, 2018-2029
6.8.5 Saudi Arabia Sodium Channel Blockers Market Size, 2018-2029
6.8.6 UAE Sodium Channel Blockers Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 SK biopharmaceuticals
7.1.1 SK biopharmaceuticals Company Summary
7.1.2 SK biopharmaceuticals Business Overview
7.1.3 SK biopharmaceuticals Sodium Channel Blockers Major Product Offerings
7.1.4 SK biopharmaceuticals Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.1.5 SK biopharmaceuticals Key News & Latest Developments
7.2 Biogen
7.2.1 Biogen Company Summary
7.2.2 Biogen Business Overview
7.2.3 Biogen Sodium Channel Blockers Major Product Offerings
7.2.4 Biogen Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.2.5 Biogen Key News & Latest Developments
7.3 Parion Sciences
7.3.1 Parion Sciences Company Summary
7.3.2 Parion Sciences Business Overview
7.3.3 Parion Sciences Sodium Channel Blockers Major Product Offerings
7.3.4 Parion Sciences Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.3.5 Parion Sciences Key News & Latest Developments
7.4 AlphaNavi Pharma
7.4.1 AlphaNavi Pharma Company Summary
7.4.2 AlphaNavi Pharma Business Overview
7.4.3 AlphaNavi Pharma Sodium Channel Blockers Major Product Offerings
7.4.4 AlphaNavi Pharma Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.4.5 AlphaNavi Pharma Key News & Latest Developments
7.5 WEX
7.5.1 WEX Company Summary
7.5.2 WEX Business Overview
7.5.3 WEX Sodium Channel Blockers Major Product Offerings
7.5.4 WEX Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.5.5 WEX Key News & Latest Developments
7.6 Vertex Pharmaceuticals
7.6.1 Vertex Pharmaceuticals Company Summary
7.6.2 Vertex Pharmaceuticals Business Overview
7.6.3 Vertex Pharmaceuticals Sodium Channel Blockers Major Product Offerings
7.6.4 Vertex Pharmaceuticals Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.6.5 Vertex Pharmaceuticals Key News & Latest Developments
7.7 RaQualia Pharma
7.7.1 RaQualia Pharma Company Summary
7.7.2 RaQualia Pharma Business Overview
7.7.3 RaQualia Pharma Sodium Channel Blockers Major Product Offerings
7.7.4 RaQualia Pharma Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.7.5 RaQualia Pharma Key News & Latest Developments
7.8 KBP Biosciences
7.8.1 KBP Biosciences Company Summary
7.8.2 KBP Biosciences Business Overview
7.8.3 KBP Biosciences Sodium Channel Blockers Major Product Offerings
7.8.4 KBP Biosciences Sodium Channel Blockers Sales and Revenue in Global (2018-2023)
7.8.5 KBP Biosciences Key News & Latest Developments
8 Global Sodium Channel Blockers Production Capacity, Analysis
8.1 Global Sodium Channel Blockers Production Capacity, 2018-2029
8.2 Sodium Channel Blockers Production Capacity of Key Manufacturers in Global Market
8.3 Global Sodium Channel Blockers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sodium Channel Blockers Supply Chain Analysis
10.1 Sodium Channel Blockers Industry Value Chain
10.2 Sodium Channel Blockers Upstream Market
10.3 Sodium Channel Blockers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sodium Channel Blockers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer